文献速递间质性肺疾病呼吸道感染

COVID-19大流行期间纤维化间质性肺病的诊疗实践考量

Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.
PubMed 文献 · Chest · 2020-04-22

本文综述COVID-19大流行对纤维化间质性肺病(ILD)患者诊断与管理的多重影响,包括诊断流程受限、常用药物不确定性、疾病监测困难及研究活动缩减,并提出应对策略与未来研究方向。

要点

  • COVID-19大流行限制了ILD诊断关键环节的可及性。
  • 常用ILD药物治疗存在新的不确定性,需权衡利弊。
  • 疾病严重度与药物不良反应的监测能力受限。

核心结论

  • COVID-19大流行直接影响纤维化ILD患者的诊断与治疗多个环节。
  • 需采取策略缓解诊断受限、药物不确定性和监测困难等挑战。
  • 未来应优先开展与COVID-19相关的ILD研究。

研究设计与样本

  • 综述类文章,总结COVID-19对纤维化ILD诊断和管理的影响。

主要发现

  • 患者面临诊断流程关键环节可及性受限。
  • 常用ILD药物治疗出现新的不确定性。
  • 疾病严重度和药物不良反应的监测能力受限。
  • 研究活动显著缩减。

临床怎么用

  • 为临床医生在COVID-19大流行期间照护ILD患者提供实践考量。
  • 为未来传染病暴发期间管理ILD患者提供路线图。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has affected virtually all aspects of patient care. Health-care systems around the world are trying simultaneously to treat patients with COVID-19, prepare for its long-term impacts, and treat patients with other acute and chronic diseases. There are multiple ways that the COVID-19 pandemic will directly affect patients with fibrotic interstitial lung disease (ILD), particularly given their common risk factors for poor outcomes. Major issues for patients with ILD will include restricted access to key components of the diagnostic process, new uncertainties in the use of common ILD pharmacotherapies, limited ability to monitor both disease severity and the presence of medication adverse effects, and significantly curtailed research activities. The purpose of this review is to summarize how COVID-19 has impacted key components of the diagnosis and management of fibrotic ILD as well as to provide strategies to mitigate these challenges. We further review major obstacles for researchers and identify priority areas for future ILD research related to COVID-19. Our goals are to provide practical considerations to support the care of patients with ILD during the COVID-19 pandemic and to provide a road map for clinicians caring for these patients during future infectious disease outbreaks.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Wong AW, Fidler L, Marcoux V, et al. Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic. Chest. 2020. PMID: 32333929. doi:10.1016/j.chest.2020.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。